Drug recall · October 16, 2019
Matzim LA recall
Why: GMP Deviation: lot not intended for commercial distribution.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by: Actabis Laboratories FL, Inc., Fort Lauderdale, FL, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 52544-692-30
- Lots / codes
Lot # 1344864A, exp. date 10/2020
- Quantity
- 5,849 bottles
- Company
- Teva Pharmaceuticals USA, Parsippany, NJ
- Distribution
- Product was distributed to 42 wholesalers and 11 retailers who may have further distribute the product throughout the United States, including Hawaii and Puerto Rico.
- Initiated
- September 6, 2019 · Voluntary: Firm initiated
- Classified
- October 9, 2019
- Reported
- October 16, 2019
- Ended
- May 19, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Matzim
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.